ERBB2 and ovarian carcinoma: For example, all patients with high levels of HER2 can benefit from therapy with trastuzumab/pertuzumab independently if their tumors have been classified as mammary HER2+, mammary HER2−, or other types of tumors, such as colon, lung, or ovarian carcinomas.